Fiche société
icometrix
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression. | SEP | À vérifier | Ralentissement de la progression | Czechia, Germany | À vérifier |
| RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression. | SEP | À vérifier | Ralentissement de la progression | Czechia, Germany | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. | SEP | À vérifier | NCT06280755 | RECLAIM — Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||